initiative OCTALFA’s mission is two fold: facilitate innovation in healthcare and provide support to vulnerable people.

Initiative OCTALFA works to bring about innovation in healthcare by incubating innovative startups in France.

Initiative OCTALFA also supports projects aimed at improving quality of life for cancer patients and disabled people in France and Madagascar.


OCTALFA creates, funds and manages young innovative companies
OTONNALE identify innovative projects until they mature into fledgling companies
The corporate foundation Fondation Dominique & Tom Alberici – OCTALFA supports charity and non-profit projects addressing the challenges surrounding cancer and disabilities in France and Madagascar
The endowment fund Institut Dominique & Tom Alberici raises additional funds for projects supported by our corporate foundation


  • Gilles Alberici

    Gilles has 30 years of experience in the pharmaceutical and biotechnology sectors. He created and developedOPi, Pharmaceuticals for Rare Diseases and has taken more than ten products through clinical trials.

  • Julien Alberici
    Managing Director

    Julien is a graduate of EMLYON Business School and iaelyon management school. He has worked as a consultant in innovation management, business development andfinancial analysis,and is currently the Chief Executive Officer and co-founder ofMathym.

  • Jeremy Bastid
    R&D Director

    Jeremy is a pharmacist and oncologist, who specialises in immuno-oncology. He joined initiative OCTALFA in 2010 and manages OREGA Biotech as Chief Operating Officer.

  • Charlotte Maddalena
    Executive Assistant

    Charlotte Maddalena joined initiative OCTALFA in October 2016 as an executive assistant. Charlotte is also responsible for the administrative management of the Foundation’s projects.

  • Laurence Simon
    Administrative and Financial Director

    Laurence Simon is Administrative and Financial Director. She has more than 15 years of experience in the biotechnology sector where she worked for OPI, Eusa Pharma and Jazz Pharmaceuticals as Financial Director. She joined the initiative Octalfa team on November 3, 2016.


Formed in 2006, OCTALFA is the fruit of previous work carried out by Gilles Alberici, in particular during his time at OPi, a company that develops drugs for orphan diseases.

OCTALFA began by helping established innovative companies with financing operations. It founded and/or invested in 14 companies in France. Since 2016, OCTALFA concentrates its efforts to the development and management of its subsidiaries.

OTONNALE identify innovative industrial or academic projects before the inception of a company dedicated to their management.

Spearheaded by Dominique Alberici, OCTALFA created the OCTALFA Corporate Foundation in 2008 to provide help for cancer patients and disabled people. The corporate foundation was named Fondation Dominique & Tom Alberici – OCTALFA in 2011, following the passing away of Tom, Dominique and Gilles’ son.

Founded in 2012, the endowment fund Institut Dominique & Tom Alberici complements the corporate foundation’s activities by supporting charity projects that require both a more hands-on approach and additional funding. This funding is provided by OCTALFA and our donors.


  • Exposition photo S'il n'y avait qu'une image

    Depuis mars 2015, Hélène Mauri intervient auprès de patients de l’Institut Curie en leur proposant de photographier un souvenir, un lieu, des proches ou encore toute chose qu’ils aimeraient avoir auprès d’eux pendant leur séjour à l’hôpital. De Nouméa à Paris, Hélène a réalisé 50 photographies dont 16 sont exposées à Ecully, près de Lyon, au centre de séminaires Valpré, du 23 octobre au 15 décembre 2018.

    Ce projet, soutenu par la Fondation Dominique & Tom Alberici-Octalfa, sera prochainement dupliqué à Lyon.

  • ORPHELIA Pharma has been awarded a €1m loan from Bpifrance
  • Interleukin-17 patent granted in Europe
  • Granting of the marketing authorization for Kigabeq®
  • All our projects

  • Irimi Vivace

    Irimi Vivace organizes musical moments in the centers for disabled (autistic or psychotic) people.

    The Foundation Dominique & Tom Alberici participates during the year 2018 in the musical workshops of the association.

  • Orphelia Pharma at Bio-Europe

    Gilles Alberici, chairman of Orphelia Pharma, will attend the 24th conference Bio-Europe in Copenhagen. Please meet on November 5 to 7.

  • CHMP has adopted a positive opinion for Kigabeq®, the first pediatric formulation of vigabatrin